The Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, Spravato (esketamine), as a ...

T ITUSVILLE, N.J. - Johnson & Johnson (NYSE:JNJ) has received approval from the U.S. Food and Drug Administration (FDA) for SPRAVATO® (esketamine) nasal spray as a standalone treatment for adults ...

We wanted something, and we're really targeting things that are just like Spravato. You go in, you get those single administration, you monitor, and then you discharge. JN: The ease of access ...

Tesla and SpaceX CEO Elon Musk clarified that he uses only "a small amount once every other week or something like that" ...

Spravato has a boxed warning about this risk. A boxed warning is the most serious warning from the Food and Drug Administration (FDA). For details, see “Boxed warnings” in the introduction of ...

Spravato has been approved since 2019 for ... by its cost and a requirement for two hours of patient observation after administration. They suggest other fast-acting antidepressants could offer ...

This is because the Food and Drug Administration (FDA) only approves the drug ketamine for use in general anesthetics. However, Medicare may cover the drug Spravato, which contains esketamine.

Living Local 15 host Jessica Williams is joined by Sean Goddard, a Psychiatric Nurse Practitioner and Owner of Viking Psychiatry, to speak about the recent approval for Spravato as a monotherapy ...

McLean Neuropsychiatric Treatment Center offers expert administration of transcranial magnetic stimulation (TMS), and esketamine (Spravato) as evidence-based treatment options for people with ...

as the Food and Drug Administration (FDA) only approves ketamine as a general anesthetic. However, it may cover Spravato, which contains esketamine. This is an FDA-approved drug that derives from ...